Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2017-06-26 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Changes to interests of a significant shareholder
Major Shareholding Notification Classification · 99% confidence The document is an official notification released via RNS (RNS Number : 2102J) by Alliance Pharma PLC. The content explicitly details a 'Change in the interests of a significant shareholder' (Mr. Nigel Wray), including the nature of the transaction ('sale of shares') and the resultant shareholding percentage (3.18% total). This structure perfectly matches the requirements for reporting personal share transactions by company directors and executives, which corresponds to the Director's Dealing category (DIRS). Although it is an RNS announcement, the specific content is highly targeted, making DIRS a more precise classification than the general RNS fallback.
2017-06-26 English
Changes to interests of a significant shareholder
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as an 'RNS Number' filing from the London Stock Exchange. The content details a 'Change in the interests of a significant shareholder' (GVQ Investment Management Limited), specifically reporting a 'sale of shares' and the resulting shareholding percentage (5.05%). This type of mandatory disclosure regarding changes in major shareholdings is specifically covered by the definition for Major Shareholding Notification (MRQ), which tracks ownership crossing thresholds. Although RNS is the source, MRQ is the specific regulatory filing type for this content, which is more precise than the general RNS fallback.
2017-06-22 English
Application for block admission
Share Issue/Capital Change Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 7891I' and 'This information is provided by RNS'). The content explicitly details an 'Application for block admission' for 25,000,000 ordinary shares to facilitate the admission of shares following the exercise of options under employee share schemes. This action directly relates to changes in the company's share capital structure and issuance of new shares. This aligns best with the 'Share Issue/Capital Change' definition (SHA). Although it is an RNS announcement, the specific subject matter (share issuance/admission) is more precise than the general fallback (RNS).
2017-06-21 English
Changes to interests of a significant shareholder
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number : 5070I' and contains a formal notification regarding a 'Change in the interests of a significant shareholder' (Mr. Nigel Wray) involving the sale of shares. The structure strongly resembles a regulatory filing mandated by exchange rules (specifically mentioning 'AIM rule 17' and 'DTR5'). The content is a specific disclosure about insider/major shareholder transactions, which aligns perfectly with the definition of Director's Dealing (DIRS) or, more broadly, a regulatory notification. Since the document explicitly details personal share transactions by an individual connected to the company (a significant shareholder/director context), the most specific code is DIRS. However, the document format is a standard regulatory announcement disseminated via RNS, and the content is a TR-1 form, which is a specific type of major shareholding notification. Given the options, 'DIRS' (Director's Dealing) covers executive/director trades, and 'MRQ' (Major Shareholding Notification) covers crossing ownership thresholds. Since this is a notification of a change in a significant shareholder's interest (crossing the 4% threshold), MRQ is highly appropriate. However, the content is fundamentally about insider/director transactions, which DIRS covers. Looking closely at the definitions, DIRS is for 'Report of personal share transactions by company directors and executives (insider trades)'. While Nigel Wray is a significant shareholder, the nature of the disclosure (TR-1) is a Major Shareholding Notification (MRQ). Since the document explicitly states it is a notification of a change in a significant shareholder's interest and includes the TR-1 form detailing the crossing of the 4% threshold, MRQ is the most precise fit for the regulatory event described, even though DIRS is related. Given the explicit mention of 'significant shareholder' and the TR-1 form structure, MRQ is selected over DIRS, which is often reserved for Form 4/8 filings in the US context, though DIRS is the closest fit for insider trading disclosures generally. Since this is a notification of a change in significant share ownership, MRQ is the best fit among the specific options provided for ownership changes.
2017-06-19 English
Application for admission
Share Issue/Capital Change Classification · 99% confidence The document is a short announcement (2247 characters) identified by an 'RNS Number' (4985I) and dated 19 June 2017. The content explicitly states that following the exercise of employee share options, an application has been made for new ordinary shares to be admitted to trading on AIM. This action directly relates to a change in the number of shares in issue, which falls under the category of Share Issue/Capital Change. The definition for 'Share Issue/Capital Change' (SHA) covers announcements regarding new share issues. Although it is an RNS announcement, the specific nature of the announcement (new shares admitted to trading) makes SHA a more precise classification than the general fallback RNS.
2017-06-19 English
Application for admission
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement (2261 characters) released via RNS (RNS Number : 1151I) by Alliance Pharma PLC. The core content announces an application for the admission of 571,000 new ordinary shares to trading on AIM following the exercise of employee share options. This directly relates to a change in the total number of shares in issue, which falls under the category of Share Issue/Capital Change. Therefore, the appropriate code is SHA.
2017-06-14 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.